ITCMDBv1
Clinical TrialID 4971

Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine

NCT00471614

HIV Infections|Insulin Resistance|Hyperlactatemia

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
4971
Evidence Id
4971
Core Evidence Id
4971
Source Clinical Trial Id
4951
Herb2 Clinical Trial Id
HBCT004951
Nct Id
NCT00471614
Title
Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
HIV Infections|Insulin Resistance|Hyperlactatemia
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DRUG: NucleomaxX (contains uridine)
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
3
Outcome Measure
Change in insulin sensitivity as measured by euglycemic hyperinsulinemic clamp (with simultaneous stable isotope tracer studies), 2 months
Sponsor Collaborator
National Center for Complementary and Integrative Health (NCCIH)
Funded By
NIH
Location
University of California San Francisco, San Francisco, California, 94110, United States
Other Id
R21AT003374-01A1
Start Date
2007-04
Primary Completion Date
2012-01
Completion Date
2012-01
First Posted
2007-05-10
Results First Posted
Last Update Posted
2012-05-16
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00471614
Title Cn
Title En
Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
Bilingual Status
semi_complete